The Evolution of Pharma Contract Manufacturing
In the ever-evolving landscape of the pharmaceutical industry, contract manufacturing has emerged as a pivotal element in the production and distribution of pharmaceutical products. According to Research and Markets , this sector has witnessed substantial growth in recent years, with the Indian Contract Manufacturing Organization (CMO) sector at the forefront of this expansion. Projected to soar from USD 19.63 billion in 2023 to a staggering USD 38.92 billion by 2028, the Indian CMO sector is set to experience a remarkable Compound Annual Growth Rate (CAGR) of 14.67%. This surge underscores the sector’s dynamic response to changing market demands, harnessing technological advancements, and the relentless pursuit of operational excellence. Let’s delve into the evolution of pharma contract manufacturing and its role in shaping the industry. The Emergence of Pharmaceutical Contract Manufacturing Pharmaceutical contract manufacturing, also known as third-party...